Plant Derived Proteins Market: Clear Understanding of The Competitive LandscapePosted by Shashii Pawar on March 3rd, 2020 The global plant derived proteins market will reach a valuation of US$ 185 Mn by 2029, witnessing a steady growth outlook during the forecast period (2019 - 2029). According to a new study by Future Market Insights (FMI), the market for plant derived proteins is largely influenced by tech transformations and R&D efforts towards recombinant proteins in the global healthcare industry. "Rising demand for passive immunization has led to the development of new plant based platforms, which could transform and express recombinant therapeutic vaccines and antibodies more effectively with improved quality, yield, and stability," reveals the FMI report. Key Research Findings of FMI's Plant Derived Proteins Market Study
Key Growth Drivers - Plant Derived Proteins Market
Key Impediments - Plant Derived Proteins Market
Competition Structure Analysis - Plant Derived Proteins Market The competition landscape of plant derived proteins market remains moderately consolidated, with a major market share being accounted by Merck KGaA and Protalix Biotherapeutic. Key producers are also pushing for strategic acquisition of smaller regional businesses in the industry to expand their regional presence and bolster existing portfolios. This also involves exploring new sources of plant based proteins such as chia and hemp. Some of the major players in the plant derived proteins market include, but are not limited to Cargill, Glanbia, ADM, Denka, Kentucky BioProcessing Inc. among others. About the Report This report offers global, regional, and national level analysis on the latest trends in the industry influencing the plant derived proteins market. The study provides actionable insights on the plant derived proteins market on the basis of plant type (tobacco, rice, carrot, barley, and others), protein (industrial proteins & enzymes, therapeutic proteins, blood proteins, cell culture functional proteins, and others), platform (in-vitro cell culture systems, whole plants, and others), application (regenerative medicine - therapeutic agents, regenerative medicine - functional material, cell culture application, and others), end user (biopharmaceutical companies, academic & research institutes, contract research organization, and contract manufacturing organizations)across 30 countries spanning seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA). About Future Market Insights (FMI) Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Contact Abhishek Budholiya Like it? Share it!More by this author |